Daigo Miyazaki

Dr. Daigo Miyazaki

Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Asahi 3-1-1, Matsumoto 390-8621, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2020 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
SUSatoru Ushiyama
Satoru Ushiyama
YSYasuhiro Shimojima
Yasuhiro Shimojima
KUKen-Ichi Ueno
Ken-Ichi Ueno
DKDai Kishida
Dai Kishida
DMDaigo Miyazaki
Daigo Miyazaki
YSYoshiki Sekijima
Yoshiki Sekijima

1 January 2010 in Rinsho Shinkeigaku
Verified
Journal Article
Open access
PDF file
TYTSUNEAKI YOSHINAGA
TSUNEAKI YOSHINAGA
DMDaigo Miyazaki
Daigo Miyazaki
KFKazuhiro Fukushima
Kazuhiro Fukushima
YSYasuhiro Shimojima
Yasuhiro Shimojima
MMMasayuki Matsuda
Masayuki Matsuda
SIShu-ichi Ikeda
Shu-ichi Ikeda
症例は73歳男性である.68歳時より四肢近位筋の筋力低下,首下がり,体重減少,皮膚硬化が緩徐に進行し,当院を受診した.顔面,頸部,上肢の高度な皮膚硬化,頸部,舌,四肢近位筋優位の全身性筋萎縮をみとめた.線維束性収縮はみとめず,深部腱反射は低下.病的反射は陰性.感覚障害はみとめなかった.血清CK値は321IU/l と軽度に上昇し,抗核抗体は陽性(5,120倍,核小体型).針筋電図にて全被検筋に筋原性変化が示され,全身性強皮症に全身性強皮症関連ミオパチーが合併したものと診断した.本症で首下がりや舌萎縮をふくむ高度の全身性筋萎縮を呈する例はまれであるが,筋萎縮症例の鑑別において留意すべき疾患と考えられた.

17 March 2025 in eLife
Verified
Journal Article
Open access
DMDaigo Miyazaki
Daigo Miyazaki
MSMitsuto Sato
Mitsuto Sato
NSNaoko Shiba
Naoko Shiba
TYTakahiro Yoshizawa
Takahiro Yoshizawa
Akinori NakamuraAkinori Nakamura
Akinori Nakamura
Becker muscular dystrophy (BMD), an X-linked muscular dystrophy, is mostly caused by an in-frame deletion of Duchenne muscular dystrophy (DMD). BMD severity varies from asymptomatic to severe, associated with the genotype of DMD. However, the underlying mechanisms remain unclear. We established BMD mice carrying three representative exon deletions: ex45–48 del., ex45–47 del., and ex45–49 del. (d45–48, d45–47, and d45–49), with high frequencies and different severities in the human BMD hotspot. All three BMD mice showed muscle weakness, muscle degeneration, and fibrosis, but these changes appeared at different times for each exon deletion, consistent with the severities obtained by the natural history study of BMD. BMD mice showed site-specific muscle changes, unlike mdx mice, which showed diffuse muscle changes, and we demonstrated selective type IIa fiber reduction in BMD mice. Furthermore, BMD mice showed sarcolemmal neuronal nitric oxide synthase (nNOS) reduction and morphological capillary changes around type IIa fibers. These results suggest that capillary changes caused by nNOS reduction may be associated with the mechanism of skeletal muscle degeneration and type IIa fiber reduction in BMD mice. BMD mice may be useful in elucidating the pathomechanisms and developing vascular targeted therapies for human BMD.

18 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
DMDaigo Miyazaki
Daigo Miyazaki
MSMitsuto Sato
Mitsuto Sato
NSNaoko Shiba
Naoko Shiba
TYTakahiro Yoshizawa
Takahiro Yoshizawa
Akinori NakamuraAkinori Nakamura
Akinori Nakamura
Becker muscular dystrophy (BMD), an X-linked muscular dystrophy, is mostly caused by an in-frame deletion of DMD . BMD severity varies from asymptomatic to severe, associated with the genotype of DMD . However, the underlying mechanisms remain unclear. We established BMD mice carrying three representative exon deletions: ex45–48 del., ex45–47 del., and ex45–49 del. (d45–48, d45–47 and d45–49), with high frequencies and different severities in the human BMD hotspot. All three BMD mice showed muscle weakness, muscle degeneration, and fibrosis, but these changes appeared at different times for each exon deletion, consistent with the severities obtained by the natural history study of BMD. BMD mice showed site-specific muscle changes, unlike mdx mice, which showed diffuse muscle changes, and we demonstrated selective type IIa fiber reduction in BMD mice. Furthermore, BMD mice showed sarcolemmal neuronal nitric oxide synthase (nNOS) reduction and morphological capillary changes around type IIa fibers. These results suggest that capillary changes caused by nNOS reduction may be associated with the mechanism of skeletal muscle degeneration and type IIa fiber reduction in BMD mice. BMD mice may be useful in elucidating the pathomechanisms and developing vascular targeted therapies for human BMD.

20 February 2025 in eLife preprints
Verified
Preprint
Open access
DMDaigo Miyazaki
Daigo Miyazaki
MSMitsuto Sato
Mitsuto Sato
NSNaoko Shiba
Naoko Shiba
TYTakahiro Yoshizawa
Takahiro Yoshizawa
Akinori NakamuraAkinori Nakamura
Akinori Nakamura
Becker muscular dystrophy (BMD), an X-linked muscular dystrophy, is mostly caused by an in-frame deletion of DMD. BMD severity varies from asymptomatic to severe, associated with the genotype of DMD. However, the underlying mechanisms remain unclear. We established BMD mice carrying three representative exon deletions: ex45–48 del., ex45–47 del., and ex45–49 del. (d45–48, d45–47 and d45–49), with high frequencies and different severities in the human BMD hotspot. All three BMD mice showed muscle weakness, muscle degeneration, and fibrosis, but these changes appeared at different times for each exon deletion, consistent with the severities obtained by the natural history study of BMD. BMD mice showed site-specific muscle changes, unlike mdx mice, which showed diffuse muscle changes, and we demonstrated selective type IIa fiber reduction in BMD mice. Furthermore, BMD mice showed sarcolemmal neuronal nitric oxide synthase (nNOS) reduction and morphological capillary changes around type IIa fibers. These results suggest that capillary changes caused by nNOS reduction may be associated with the mechanism of skeletal muscle degeneration and type IIa fiber reduction in BMD mice. BMD mice may be useful in elucidating the pathomechanisms and developing vascular targeted therapies for human BMD.